Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Sinusitis Bacterial Clinical Trial
Point-of-Care Immunoassay for Detection of Bacterial Sinusitis
Status: Enrolling, Phase
Updated: 12/31/1969
Tandem Clinical Research
mi
from
Marrero, LA
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018/PNEU-WAY)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Crofoot Research Center, Inc. ( Site 0118)
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern Medical Center; Pediatrics Dept.
mi
from
Dallas, TX
Click here to add this to my saved trials
Vestibular Disorder Clinical Trial
Vestibular Treatment in Adolescents Following Sport Related Concussion
Status: Enrolling
Updated: 12/31/1969
UMPC Sports Medicine Concussion Research Program
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph's Clinical Research
mi
from
Anaheim, CA
Click here to add this to my saved trials
Cardiac Surgery Clinical Trial
QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Westmead Hospital
mi
from
Westmead,
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Study of NKTR-358 in Participants With Systemic Lupus Erythematosis (SLE)
Status: Enrolling, Phase I
Updated: 12/31/1969
MiddleBurg Heights
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Academic Centers Research and Education
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Covington, LA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0015 965
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0016 701
mi
from
High Point, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0002 207
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0008 936
mi
from
Tampa, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0003 313
mi
from
West Dundee, IL
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0011 733
mi
from
Wilmington, NC
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
mi
from
Georgetown, KY
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Vancouver, WA
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clin. Rsrch Inst. of Michigan
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Qway Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Southtowns Gastroenterology, PLLC
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Allergic Rhinitis Clinical Trial
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Allergic Rhinitis Clinical Trial
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Obsessive-Compulsive Disorder Clinical Trial
Initial Development and Dissemination of OC-Go
Status: Enrolling, Phase
Updated: 12/31/1969
Univ. of California / Los Angeles / Semel Inst.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Epigenetic Reprogramming in Relapse/Refractory AML
Status: Enrolling, Phase I
Updated: 12/31/1969
Sydney Children's Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression
Status: Enrolling, Phase II
Updated: 12/31/1969
Irvine Clinical Research
mi
from
Irvine, CA
Click here to add this to my saved trials
Asthma Clinical Trial
Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Asthma Clinical Trial
Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology P A
mi
from
Dallas, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Hca Midwest Division
mi
from
Kansas City, MO
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Sedona, AZ
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists Panhandle
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Metastatic Colorectal Cancer Clinical Trial
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Status: Enrolling, Phase II
Updated: 12/31/1969
Trinity Health Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Albany, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Medicine, University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jamaica, NY
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Missoula, MT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Indu and Raj Soin Medical Center
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Elizabeth Boardman Hospital
mi
from
Boardman, OH
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Laurens
mi
from
Clinton, SC
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton Physician LLC-Miami Valley Hospital North
mi
from
Dayton, OH
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
The Women's Imaging Center
mi
from
Denver, CO
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lymphoma Clinic of Michigan
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Center of The South Incorporated
mi
from
Houma, LA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional West Medical Center Cancer Center
mi
from
Scottsbluff, NE
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Medical Oncology-Selinsgrove
mi
from
Selinsgrove, PA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Bhadresh Nayak MD PC-Sterling Heights
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Thief River Falls Medical Center
mi
from
Thief River Falls, MN
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Professional Building
mi
from
Warren, MI
Click here to add this to my saved trials
Transtibial Amputee Clinical Trial
Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees
Status: Enrolling
Updated: 12/31/1969
University of Washington Bioengineering
mi
from
Seattle, WA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Metastatic Solid Tumors of Metastatic Disease Clinical Trial
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Metastatic Solid Tumors of Metastatic Disease Clinical Trial
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Nassau
mi
from
Uniondale, NY
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
ClinRX Research Joseph INC
mi
from
Carrollton, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Tandem Clinical Research
mi
from
Marrero, LA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Professional Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Kerato Conjunctivitis Sicca Clinical Trial
Safety and Efficacy of KPI-121 in Subjects With DED
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials